A systematic review of pharmacoeconomic studies for pregabalin.

about

Clinical utility, safety, and efficacy of pregabalin in the treatment of fibromyalgia

P2860

Q26764876-B0E4C38B-3352-494F-96ED-D756E1899583

P2860

A systematic review of pharmacoeconomic studies for pregabalin.

Item

http://www.wikidata.org/entity/Q38210750

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

A systematic review of pharmacoeconomic studies for pregabalin.

@en

type

Item

label

A systematic review of pharmacoeconomic studies for pregabalin.

@en

prefLabel

A systematic review of pharmacoeconomic studies for pregabalin.

@en

P1476

A systematic review of pharmacoeconomic studies for pregabalin.

@en

P2093

Joaquin Mould

http://www.w3.org/2001/XMLSchema#string

Lindsay Parker

http://www.w3.org/2001/XMLSchema#string

Rachel Huelin

http://www.w3.org/2001/XMLSchema#string

Radek Wasiak

http://www.w3.org/2001/XMLSchema#string

Zarmina Khankhel

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathic pain: a practical guide for the clinician

An internet survey of 2,596 people with fibromyalgia

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

A cost-consequences analysis of the effect of pregabalin in the treatment of peripheral neuropathic pain in routine medical practice in primary care settings.

Classification, epidemiology, and natural history of fibromyalgia.

A cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.

Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy.

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis.

Gabapentin and pregabalin for chronic neuropathic and early postsurgical pain: current evidence and future directions.

P304

82-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PAPR.12193

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262226230

http://www.w3.org/2001/XMLSchema#string

P698

24815038

http://www.w3.org/2001/XMLSchema#string

A systematic review of pharmacoeconomic studies for pregabalin.

about

P2860

P2860

A systematic review of pharmacoeconomic studies for pregabalin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698